Kunkel Lori Anne bought ORIC
January 2, 2026 · Form 4 insider transaction
Kunkel Lori Anne bought 40,000 shares of ORIC Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
40,000
Price
$0.00
Total value
N/A
InsiderKunkel Lori Anne
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 6, 2026
Shares owned after40,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2026.